Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering

Sign In \| Register \| About Walnut Creek Guide \| Contact Us
Walnut Creek, CA September 01, 2020 1:43pm 7-Day Forecast \| Traffic

- American
- Bakery
- Brew Pubs
- Coffee Houses
- Eating Places
- Fast Food
- German
- Greek
- Hawaiian
- Italian
- Jewish
- Latin American
- Lebanese
- Mediterranean
- Pizza
- Seafood
- Soul Food
- Sports Bars
- Steaks, Chops
- Thai
- Wine
- Apartments
- Classifieds
- Cars
- Forums
- Coupons
- News Archives
- Contests
- Jobs

Recent Quotes

My Watchlist

Indicators

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search Hotels in Walnut Creek Guide

Find A Business

or Browse Listings

Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering